Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$1.27B |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$1.23B |
| 3 |
SPDR Gold Trust
GLD
|
+$710M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$662M |
| 5 |
Abbott
ABT
|
+$459M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.33B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$932M |
| 3 |
TransDigm Group
TDG
|
+$833M |
| 4 |
MPLX
MPLX
|
+$616M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$593M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.4% |
| 2 | Financials | 10.07% |
| 3 | Consumer Discretionary | 8.39% |
| 4 | Healthcare | 7.69% |
| 5 | Communication Services | 6.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TLP
3901
DELISTED
Transmontaigne
TLP
| $2.08M | ﹤0.01% |
58,207
-34,863
| -37% | -$1.34M |
|
3902
Astronics
ATRO
$3.78B
| $2.08M | ﹤0.01% |
77,085
+13,565
| +21% | +$405K |
|
3903
LivePerson
LPSN
$25.4M
| $2.08M | ﹤0.01% |
8,490
-4,620
| -35% | -$925K |
|
3904
VanEck International High Yield Bond ETF
IHY
$43.2M
| $2.08M | ﹤0.01% |
81,392
+75,529
| +1,288% | +$1.94M |
|
3905
Invesco CurrencyShares Australian Dollar Trust
FXA
$97.8M
| $2.07M | ﹤0.01% |
26,966
-8,597
| -24% | -$676K |
|
|
RPT
3906
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
| $2.07M | ﹤0.01% |
167,590
+9,126
| +6% | +$116K |
|
|
CMO
3907
DELISTED
Capstead Mortgage Corp.
CMO
| $2.07M | ﹤0.01% |
239,238
-144,575
| -38% | -$1.25M |
|
|
BHVN
3908
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $2.07M | ﹤0.01% |
80,296
+49,179
| +158% | +$1.47M |
|
3909
ProShares UltraPro S&P 500
UPRO
$5.68B
| $2.07M | ﹤0.01% |
94,860
-168,990
| -64% | -$4.16M |
|
3910
State Street SPDR Portfolio Europe ETF
SPEU
$740M
| $2.07M | ﹤0.01% |
59,660
-13,954
| -19% | -$502K |
|
|
JPMV
3911
DELISTED
iShares Edge MSCI Min Vol Japan ETF
JPMV
| $2.06M | ﹤0.01% |
29,443
-176,138
| -86% | -$12.2M |
|
3912
Accuray
ARAY
$34.1M
| $2.06M | ﹤0.01% |
412,625
-190,996
| -32% | -$1M |
|
3913
1st Source
SRCE
$2.17B
| $2.06M | ﹤0.01% |
40,730
-12,443
| -23% | -$638K |
|
3914
OneSpan
OSPN
$612M
| $2.06M | ﹤0.01% |
159,148
+34,376
| +28% | +$469K |
|
3915
Gladstone Investment Corp
GAIN
$657M
| $2.06M | ﹤0.01% |
203,955
-65,877
| -24% | -$687K |
|
|
THR
3916
DELISTED
Thermon Group Holdings
THR
| $2.06M | ﹤0.01% |
91,771
+13,942
| +18% | +$321K |
|
|
CNCE
3917
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $2.06M | ﹤0.01% |
89,858
-98,175
| -52% | -$2.18M |
|
|
INB
3918
DELISTED
Cohen & Steers Global Income Builder, Inc.
INB
| $2.06M | ﹤0.01% |
225,050
-267,040
| -54% | -$2.58M |
|
3919
York Water
YORW
$498M
| $2.05M | ﹤0.01% |
66,176
+5,922
| +10% | +$183K |
|
|
SCX
3920
DELISTED
The L.S. Starrett Company
SCX
| $2.05M | ﹤0.01% |
303,196
+5,817
| +2% | +$47.2K |
|
3921
Invesco Global ex-US High Yield Corporate Bond ETF
PGHY
$226M
| $2.04M | ﹤0.01% |
86,575
+2,056
| +2% | +$48.9K |
|
3922
Aclaris Therapeutics
ACRS
$869M
| $2.04M | ﹤0.01% |
116,578
-71,137
| -38% | -$1.51M |
|
|
SFIX
3923
Stitch Fix
SFIX
$562M
| $2.04M | ﹤0.01% |
100,704
+16,776
| +20% | +$363K |
|
|
JTD
3924
DELISTED
NUVEEN TAX-ADVANTAGE DIVIDEND GROWTH FUND
JTD
| $2.04M | ﹤0.01% |
124,660
-152,513
| -55% | -$2.66M |
|
3925
Medpace
MEDP
$16.2B
| $2.04M | ﹤0.01% |
58,315
+5,251
| +10% | +$192K |
|
Similar funds
Morgan Stanley's Q1 2018 Portfolio in Review
As of Q1 2018, Morgan Stanley held 6,930 positions worth $360B, down 1.4% from $365B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Trading was light in Q1 2018: portfolio turnover was 4.7%. Morgan Stanley opened 170 new positions and exited 155, leaving the 6,930-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Consumer Discretionary.
- Morgan Stanley's largest Q1 2018 buy was Nutrien: 1,554,481 shares worth $73.5M.
- Morgan Stanley added most to iShares Russell 2000 ETF in Q1 2018, an estimated $1.27B increase.
- Morgan Stanley's biggest Q1 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.33B.
- Morgan Stanley fully exited Juno Therapeutics, Inc. in Q1 2018, selling an estimated $86M.
- Morgan Stanley's ten largest holdings make up 14% of its $360B portfolio in Q1 2018.
- Morgan Stanley opened 170 new positions and closed 155 in Q1 2018.
- Morgan Stanley's portfolio value fell 1.4% quarter-over-quarter to $360B.
Based on Morgan Stanley's 13F filing for Q1 2018, filed 14 May 2018.